
Regulatory Pathway for Licensing Biotherapeutics in Mexico.
Fecha de publicación: 2 abril de 2020 Development and Evaluation of a Set of Spike and Receptor Binding Domain‐Based...
Determination of Peptide Profile Consistency and Safety of Collagen Hydrolysates as Quality Attributes. VER MÁS
Efficacy, Pharmacokinetics, and Toxicity Profiles of Broad Anti-SARS-CoV-2 Neutralizing Antibody. VER MÁS
Fecha de publicación: 28 de agosto de 2022 Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies Ver más
Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy. VER MÁS
Taking advantage of a high-throughput flow cytometer for the implementation of an ADCC assay for regulatory compliance. VER MÁS
Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc región....
Mycobacterium tuberculosis Catalase Inhibits the Formation of Mast Cell Extracellular Traps. VER MÁS

+52 (55) 5729 6000 Ext. 62543
Escuela Nacional de Ciencias Biológicas. Prolongación de Carpio y Plan de Ayala S/N, Del. Miguel Hidalgo, CDMX, C.P. 11340.
©2026 UDIBI